Literature DB >> 7276800

Androgen and oestrogen binding in cytosols of human ovarian tumours.

T C Hamilton, P Davies, K Griffiths.   

Abstract

The specific retention of androgens and oestrogens by cytoplasmic components of human ovarian tumours was investigated. High-affinity, low-capacity binding of androgens was observed in 88% of tumour specimens and oestrogen binding in 32%. Retention of oestrogens did not occur in the absence of androgen binding. The androgen-binding component, of sedimentation coefficient 7.5-8.5S, showed specificity for 5 alpha-dihydrotestosterone and 17 beta-hydroxy-17 alpha-methyl-estra-4,9,11-trien-3-one (R1881). In some instances, competition for R1881-binding sites indicated the presence of progesterone receptor-like binding. The data presented suggest strongly the existence of androgen and oestrogen receptors in some ovarian tumours and may be relevant to histopathological classification and therapeutic rationales.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276800     DOI: 10.1677/joe.0.0900421

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  12 in total

1.  Ovarian surface epithelium receptors during pregnancy and estrus cycle of rats with emphasis on steroids and gonadotropin fluctuation.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2014-03-13       Impact factor: 4.219

2.  Hormonal aspects of ovarian malignancy.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

3.  Estrogen stimulation of ovarian surface epithelial cell proliferation.

Authors:  W Bai; B Oliveros-Saunders; Q Wang; M E Acevedo-Duncan; S V Nicosia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

4.  Isolation and characterization of rabbit ovarian surface epithelium, granulosa cells, and peritoneal mesothelium in primary culture.

Authors:  G N Piquette; B G Timms
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

Review 5.  Sex steroid receptors in endometrial cancer.

Authors:  J T Chambers
Journal:  Yale J Biol Med       Date:  1988 Jul-Aug

6.  Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.

Authors:  R J Osborne; S T Malik; M L Slevin; V J Harvey; J Spona; H Salzer; C J Williams
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

7.  The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

Authors:  P Thompson; P Wilson; R Osborne; M Slevin; F Wiltshaw; P Blake; P Harper; R Coleman; C Williams; J Sweetenham
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

8.  The human ovarian surface epithelium is an androgen responsive tissue.

Authors:  R J Edmondson; J M Monaghan; B R Davies
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

Review 9.  The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.

Authors:  Haiyan Zhu; Xuejie Zhu; Lihong Zheng; Xiaoli Hu; LuZhe Sun; Xueqiong Zhu
Journal:  Oncotarget       Date:  2017-04-25

Review 10.  A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus.

Authors:  Purab Pal; Kara Nicole Starkweather; Karen Held Hales; Dale Buchanan Hales
Journal:  Comp Med       Date:  2021-07-29       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.